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Abstract
Menin is the protein product of the MEN1 tumor-
suppressor gene; one allele of MEN1 is inactivated in
the germ line of patients with ‘‘multiple endocrine neo-
plasia type 1’’ (MEN1) cancer syndrome. Menin interacts
with several proteins involved in transcriptional regula-
tion. RNA expression analyses have identified several
menin-regulated genes that could represent proximal or
distal interaction sites for menin. This report presents a
substantial and unbiased sampling of menin-occupied
chromatin regions using Serial Analysis of Chromatin
Occupancy; this method combines chromatin immuno-
precipitation with Serial Analysis of Gene Expression.
Hundreds of menin-occupied genomic sites were iden-
tified in promoter regions (32% of menin-occupied loci),
near the 3V end of genes (14%), or inside genes (21%),
extending other data about menin recruitments to many
sites of transcriptional activity. A large number of menin-
occupied sites (33%) were located outside known gene
regions. Additional annotation of the human genome
could help in identifying genes at these loci, or these
might be gene-free regions of the genome where menin
occupancy could play some structural or regulatory role.
Menin occupancy at many intragenic positions distant
from the core promoter reveals an unexpected type of
menin target region at many loci in the genome. These
unbiased data also suggest that menin could play a
broad role in transcriptional regulation.
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Introduction
Multiple endocrine neoplasia type 1 (MEN1) is a cancer syn-
drome predisposed by heterozygous germ-line mutations
in the MEN1 tumor-suppressor gene (OMIM no. 13110).
Somatic inactivation of the normal MEN1 allele in a pre-
disposed cell initiates clonal tumor of parathyroid, enter-
opancreatic neuroendocrine, anterior pituitary, or other
tissues [1]. Biallelic somatic loss of MEN1 has also been
detected commonly in sporadic tumors of similar tissues [1].
TheMEN1-encoded menin protein is expressed in all normal tis-
sues and is predominantly nuclear [2]. Menin interacts with
a variety of transcription factors and chromatin-modifying
proteins: AP1 transcription factor JunD; NFnB proteins p50,
p52, and p65; homeobox-containing protein Pem; TGFb-
induced protein Smad3; BMP-2– induced proteins Smad1,
Smad5, and Runx2; corepressor mSin3A; and the MLL1/
MLL2–containing COMPASS-like protein complex (reviewed
in Agarwal et al. [3]). These interactions of menin with tran-
scriptional regulatory proteins can produce either a suppressing
effect or an enhancing effect on gene expression. Therefore,
transcriptional regulation (without menin necessarily binding
directly to specific DNA sequence) seems to be an important
physiological activity of menin.
Analysis of menin target genes is an obvious avenue to
understanding menin’s function. Direct participation of menin
in the regulation of some genes (Hoxa7, Hoxa9, Hoxa10,
Hoxc8, FoxC1, FoxC2, hTERT, IGFBP2, Meis1, p18, and
p27 ) has been suggested by chromatin immunoprecipitation
(ChIP) analyses [3–10]. Furthermore, in specific promoter-
based luciferase assays, overexpression of menin modulated
the promoter activity of p18, p27, rat insulin, human prolactin,
human cFos, human PAI2, and mouse IGFBP2 [3,11]. In
addition, cDNA or oligonucleotide microarray techniques have
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revealed menin-regulated genes by comparing gene ex-
pressions in cell lines (vector-transfected versus MEN1-
transfected) [5,7,12–14], inMen1+/+ versus Men1/mouse
embryos [5], or in human MEN1 tumors [15,16]. Menin target
genes in one tissue have shown minimal overlap with menin
target genes in other tissues.
Recent advances in applying ChIP with DNA microarray
(ChIP chip) or cloning techniques have been helpful in
identifying novel target genes or DNA-binding sites of several
proteins in the context of the whole genome [17–21]. These
methods have shown that selected proteins with binding-site
specificity occupy far more DNA sites than previously sus-
pected. Serial Analysis of Chromatin Occupancy (SACO) is
one such approach that combines ChIP with Serial Analysis
of Gene Expression (SAGE) technique, and it has been
successfully used to identify genomewide cAMP-responsive
element-binding protein (CREB) targets [18]. Unlike CREB,
menin does not possess any obvious DNA-binding domain
nor are there any specific recognized DNA sequences that
bind menin. Thus, menin’s binding to DNA may possibly be
indirectly facilitated by partnership with other transcriptional
regulators. In the current report, SACO is used to survey
menin-binding sites in human genomic DNA.
Materials and Methods
Cell Culture and Antibodies
HeLa-S3 cells (ATCC, Manassas, VA) were grown in
complete Dulbecco’s modified Eagle’s medium (supple-
mented with 10% fetal calf serum, 2 mM glutamine, and
100 mg/ml penicillin–streptomycin) at 5% CO2. Normal rab-
bit IgG was purchased from Santa Cruz Biotechnologies
(Santa Cruz, CA), and antimenin (BL342) was obtained from
Bethyl Laboratories (Montgomery, TX).
ChIP
HeLa cells were fixed at room temperature in 1% formal-
dehyde/1 phosphate-buffered saline (PBS) for 20 min-
utes. Cells were scraped in cold harvesting buffer (100 mM
Tris–HCl pH 9.4 and 10 mM DTT) and pelleted by centrifu-
gation at 3000g for 5 minutes at 4jC. Cell pellets were
washed with cold 1 PBS, and 107 cells were lysed in
0.6 ml of lysis buffer [20 mM Tris–HCl pH 8.0, 150 mM NaCl,
0.1% sodium dodecyl sulfate (SDS), 0.5% Triton X-100, and
protease inhibitors (Roche Molecular Biochemicals, India-
napolis, IN)]. Chromatin lysates were sonicated with an
ultrasonic processor (Model GE 750; PGC Scientific, Fred-
erick, MD) to an approximate DNA size of 1000 bp and below,
then centrifuged for 10 minutes at 13,000 rpm at 4jC. Super-
natants were transferred to fresh tubes, and each 0.6-ml
aliquot of the lysate was precleared with 80 ml of washed
and bovine serum albumin (BSA)–blocked 50% protein
A-Sepharose (Amersham Pharmacia, Piscataway, NJ) by
rocking for 1 hour at 4jC. Immunoprecipitation was per-
formed overnight at 4jC with 4 mg of antimenin antibody or
normal rabbit IgG as control. Immune complexes were cap-
tured with 80 ml of 50% protein A-Sepharose slurry for 1 hour
at 4jC. Beads were collected by centrifugation at 8000 rpm
for 1 minute and washed as follows: four times in lysis buffer
for 10minutes, once in LiCl buffer (0.25MLiCl, 1%NP-40, 1%
deoxycholate, 1 mM EDTA pH 8.0, and 10 mM Tris–HCl
pH 8.0), once with 1 TE pH 8.0 for 30 minutes, and then
once with 1 TE for 5 minutes. Chromatin protein/DNA com-
plexes were eluted from the beads twice by adding 100 ml of
elution buffer (1% SDS and 0.1 M NaHCO3 pH 8.0) at room
temperature for 15 minutes each. The beads were collected
by centrifugation at 13,000 rpm for 1 minute, and eluates
were pooled and heated at 65jC overnight to reverse cross-
links. DNA fragments were purified using the QIAquick PCR
purification kit (Qiagen, Valencia, CA).
SACO Library
A SACO library was prepared using antimenin ChIP DNA
obtained from 6  107 HeLa cells [18]. An outline of the
menin–SACO library construction is shown (Figure W1). A
modified version of the Long-SAGE protocol [22] was used
to create ditags. Ditag concatemers were cloned into pZErO
(Invitrogen, Carlsbad, CA) kanamycin vector and trans-
formed by electroporation into E. cloni 10G electrocompetent
cells (Lucigen, Middleton,WI). This antimenin plasmid SACO
library was titered, and glycerol stocks were prepared from
transformed bacteria. The average number of ditags in
plasmids was analyzed by polymerase chain reaction
(PCR) using vector primers flanking the insert.
SACO Data Analysis and Bioinformatics
Sequencing of SACO library plasmids was performed at
Rexagen/Regulome (Seattle,WA). Approximately 5000 plas-
mids were sequenced to obtain the sequence of at least
40,000 tags. Concatemer sequences were extracted from
chromatograms with the base caller ‘‘phred’’ using recom-
mended settings [23]. A custom ‘‘perl’’ script separated ditags
at all CATGs. Duplicate sequences were removed from the
analysis (same set of concatemerized tags). The resulting
21-bp SACO genomic signature tags (GSTs) were matched
to genomic CATG sites using a C program. GSTs with exact
matches or matches with one substitution error that were
uniquely assignable to a genomic location were considered
as positives. GSTs without a unique genomic match or with
multiple unique matches were not considered. GSTs within
2 kb of each other were taken to be associated with the same
locus. A set of scripts that automate the analysis of SACO
data is available online at http://genome.bnl.gov/SACO/.
Menin –SACO raw data are available at http://saco.
ohsu.edu/. Additional details on the analysis of SACO loci
have been published [18].
ChIP–PCR Analysis of Menin-Occupied Loci
The genomic sequence (2 kb) flanking the GST median
was copied from ENSEMBL. Primers were designed using
MIT’s (Whitehead Institute, Cambridge, MA) Primer3 soft-
ware (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.
cgi) such that primer pairs would amplify 200- to 300-bp
products located close to the GST. Primer sequences are
available on request. For GST confirmation, independent
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ChIP assays were performed using 6  107 HeLa cells.
Quantitative PCR (qPCR; 25 ml) reactions were performed
in duplicate using Mx3000P (Stratagene, La Jolla, CA) and
the SYBR-green qPCR kit (Stratagene). PCR conditions
were as follows: 95jC for 10 minutes; 40 cycles of 95jC for
30 seconds, 55jC for 60 seconds, and 72jC for 30 s. Anti-
menin and rabbit IgG ChIPs were expressed as nanograms
of gel-purified (Qiagen) amplicon. Products showing a
greater-than-two-fold enrichment relative to an IgG control
were considered confirmed. Each amplicon was analyzed by
agarose gel electrophoresis, and those yielding multiple
products or no products were discarded and primers were
redesigned. Other primer pairs used for ChIP–PCR were as
follows: positive control primer pairs for Hoxc8 and Hoxa9
promoters, and seven negative control primer pairs (ch12:
2997, H2A, H2B, ch12:6151, LRP, MycP2, and Tubulin).
HeLa RNA Expression Analysis
Total RNA was isolated from two independent culture
dishes of exponentially growing HeLa cells with Trizol (Invi-
trogen) and further purified using RNAeasy (Qiagen). Each
sample was analyzed at the National Institute of Diabetes
and Digestive and Kidney Diseases (NIDDK) microarray
core facility using Affymetrix microarray platform (Affymetrix,
Santa Clara, CA). Labeled samples were hybridized to
Affymetrix human genome U133 Plus 2.0 array. Micro-
array data were normalized and analyzed using Affymetrix
GeneChip software Microarray Analysis Suite 5.0. Expres-
sion levels were assigned based on positive or negative
signals for gene expression, as per Affymetrix’s detection
call of ‘‘present’’ or ‘‘absent’’ (a signal intensity of > 200
arbitrary units was considered ‘‘present’’).
Results and Discussion
Menin–SACO Library
Menin expression has been detected in all tissues and cell
lines studied so far, except in menin-null tumor tissues or
menin-null mouse embryo fibroblasts (MEFs). HeLa cells
have been used for performing transcriptional reporter as-
says involving menin-interacting proteins and for isolating a
menin-containing COMPASS-like protein complex. Hence,
menin activities and targets almost certainly exist in HeLa
cells. Thus, HeLa cells seemed appropriate for the initial
analysis of menin-associated targets at a genomic scale. A
SACO library was prepared from a HeLa cell chromatin
extract after ChIP with an antimenin antibody. The menin–
SACO library contained in excess of 3  106 GSTs. Close to
5000 plasmids containing concatemerized ditags were
sequenced, and after removing duplicate sequences (pos-
sessing the same order of tags in concatemers), the se-
quence from 38,743 GSTs was analyzed. This may not be
sufficient for an exhaustive analysis of menin targets in the
entire genome. But a representative sampling of menin
occupancy across the genome was accomplished. Of the
38,743 GSTs, 32,956 were distinct, of which 22,191 (67%)
could be mapped to unique loci in the current build of the
human genome sequence (Hg 17). A total of 8369 (25%)
GSTs mapped to multiple locations belonging to repetitive
sequences, and 2396 (8%) GSTs could not be located in
the human genome sequence. The specificity of SAGE-
type library analysis is increased by considering loci repre-
sented by multiple tags or GSTs [24]. Single hits increase
the number of menin targets by eight-fold. The number of
likely false positives makes analysis of this data set of single
hits difficult and unreliable. Other groups working with tech-
niques similar to SACO also do not consider single hits in
their analysis of target loci [e.g., in the analysis of p53 target
loci (by ChIP PET) using two statistical analysis methods,
Wei et al. [21] concluded that singletons were most likely
background, and Kim et al. [19] have shown that identifica-
tion of chromosomal targets by sequence tag analysis of
genomic enrichment (STAGE) could be validated by inde-
pendent methods when target genes were designated by
multiple occurrences of STAGE tags). Therefore, all analyses
of the menin–SACO library focused on loci represented by
more than one GST (Figure 1). These include 2616 GSTs
representing 1162 unique loci (unique locus = GSTs mapping
within 2 kb of each other). The 2-kb interval was chosen
based on a natural cutoff in the distribution of GSTs [18].
Identification of Menin-Occupied Loci
Among the 1162 menin-occupied loci represented by
multiple GSTs, 778 (67%) loci mapped to at least one mRNA
or gene predicted by ECgene EST and mRNA clustering
annotation (UCSC genome browser). These consisted of
371 (32%)GSTs located within 2 kb of the 5V end of annotated
genes (defined as the most 5V region of UCSC ‘‘known gene’’
or ENSEMBL gene annotation), 163 (14%) GSTs located
within 2 kb of the 3V end of annotated genes, and 244 (21%)
Figure 1. Characterization of clones in the menin–SACO library. Partial se-
quencing of the menin –SACO library identified 1162 menin target loci; 778 of
these loci were distributed near annotated or predicted genes within 2 kb of
the 5 V end, the 3 V end, or inside genes. GSTs = genomic signature tags.
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GSTs located inside genes (not within 2 kb of the 5V and 3V
ends of a gene). The rest of the 384 (33%) menin-occupied
loci were located > 2 kb away from any known or predicted
gene. The 778 loci represented 635 characterized genes.
These 635 genes included 157 genes that encoded hypo-
thetical/predicted proteins. Note that a single gene could
be represented bymultiplemenin-occupied loci if the ‘‘ unique
loci’’ mapped within or > 4 kb from each other in the same
gene. This was observed for 70 genes in the current data set.
The properties of these 70 genes were unremarkable.
Thus, as expected, menin was predominantly located
near the 5V ends of annotated genes; at the same time,
the surprisingly high frequency of menin occupancy at the
3V end and inside genes could be explained by the location of
as yet unknown regulatory elements or unknown genes in
these regions.
Confirmation of Menin Occupancy at Target Loci
ChIP followed by PCR (ChIP–PCR) was performed for
51 menin-occupied loci represented by more than one GST
and located within 2 kb of the 5V end of annotated genes.
qPCR of antimenin ChIP DNA from HeLa cells confirmed
menin occupancy at 94% (48 of 51) of loci, specifically en-
riched by more than two-fold over anti-IgG ChIP control
(range of fold change, 0.12–10.0) (Figure 2). qPCR data
also verified menin occupancy at the Hoxc8 and Hoxa9
promoter regions that have been previously reported as
menin targets [5,9,10,25]. Negative control primer pairs
(n = 7) did not show a > 1.6-fold enrichment over anti-IgG
ChIP control (range of fold change, 1.1–1.6). Also tested
were 26 menin-occupied loci that mapped inside genes
(Figure 2), of which 24 showed a more-than-two-fold en-
richment in the antimenin ChIP over IgG control ChIP (range
of fold change, 1.7–16.5). Therefore, almost each of the
menin-occupied genomic loci identified by sequencing the
menin–SACO library was also enriched in independent
ChIP–PCR analysis, confirming the robustness of menin-
binding sites identified by SACO.
Characterization of Menin-Occupied Loci
The current study has identified many menin-occupied
DNA sites outside the 5V end of genes. The SACO analysis
reported here is consistent with an independent approach
that we have used [26] with ChIP chip and arrays contain-
ing 20,000 human promoters, an end-to-end coverage of
381 genes, and an additional 20 Mb on chromosome 7. Both
analyses showed many interaction loci of menin in promoter
regions, but also many other menin interaction loci outside
these regions. The sensitivity of detecting weaker direct
protein–DNA interactions or weaker indirect protein–
protein–DNA interactions would depend on the quality of
the ChIP step that is common to both SACO and ChIP chip.
Therefore, both techniques would be equally handicapped
in being sensitive to weak interactions. With the current
menin–SACO data set, a representative sampling of menin
occupancy across the genome was accomplished. From
ChIP chip menin data, there were at least 1706 promoters
in HeLa cells that bound menin. In the present report, after
partial sequencing of the menin–SACO library, 371 menin-
occupied loci were found near promoter regions. The ChIP
chip approach may indeed have missed some targets.
Therefore, we estimate that approximately 22% (or less) of
the genome is being interrogated with the current menin–
SACO data set. A comparison has not yet been performed
between SACO-identified menin-occupied sites and those
sites identified by ChIP chip analysis in HeLa cells.
A location map of the 1162 menin-occupied loci using
‘‘ENSEMBL KaryoView’’ (http://www.ensembl.org/Homo_
sapiens/karyoview) showed even distribution among sub-
chromosomal loci (data not shown). No significant asso-
ciation of menin GSTs at regions of gene clustering was
observed when we examined this subchromosomal dis-
tribution of menin-occupied loci.
It is important to identify the nature of menin-occupied
DNA sites and to understand menin’s functions at sites of
menin occupancy. Menin is known to regulate AP1-activated
transcription at AP1-binding sites [27,28]. A directed search
for AP1-binding sites ‘‘TGAGTCA’’ or ‘‘TGACTAA’’ near the
1162 menin-occupied loci (using a 1-kb flanking sequence)
revealed that these sites occurred at a frequency of 7.14 
105 and 6.28  105, respectively. These frequencies were
not significantly higher than the frequency in the human
genome of ‘‘TGAGTCA’’ (8.08  105) or the frequency of a
random heptanucleotide (6.52  105) with the same GC
content as the AP1-binding site [29].
Figure 2. qPCR of ChIPs as an index of menin occupancy. Enrichment of
menin occupancy is shown as fold change over IgG ChIP–PCR for each
category. Shown are the interquartile range (black box), median (white line
on the black box), and overall range (black line). Primer pairs used: Neg =
negative control (n = 7); Pos = positive control (n = 2; Hoxc8 and Hoxa9);
5 V end = GSTs mapping to the 5 V end of genes (n = 51); Inside = GSTs
mapping inside genes and not within 2 kb of the 5 V end or the 3 V end of a gene
(n = 26). The nucleotide position of each GST analyzed by ChIP–PCR and
the fold change over IgG are shown (Table W3).
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Sequence analysis of the DNA-binding site motifs of other
menin-interacting transcription factors was not performed
because either their consensus-binding sites were not known
(Pem, Ches1), the sequence was small (CAGA for Smad
proteins), or the consensus sequence was variable and
sequence subunit specificity for the binding site was not
known (GGGRNNYYCCC for NFnB-p50, NFnB-p52, and
NFnB-p65). We are interested in performing these analyses
when more extensive data are available. In addition, Smad
proteins have been reported to regulate transcription from
AP1 sites [30]. Furthermore, the AP1 transcription factor
JunD is our favored candidate and is, so far, the most prom-
ising candidate as a valid menin partner. We have also tried
to find a common menin–DNA interaction motif at the 1162
menin-occupied loci represented by multiple GSTs, but
searches have so far not been successful (unpublished data).
It is not known if any of the 244 intragenic menin-occupied
regions participates in transcriptional regulation. The func-
tional significance of factor occupancy at intragenic loci and
the role of intragenic loci in regulating transcription are being
actively pursued in several laboratories [18,21,31]. There-
fore, further studies might also shed light on the role of
menin occupancy at intragenic loci. Given menin’s pres-
ence in protein complexes that modify transcriptionally ac-
tive chromatin, one possibility is that menin occupancy
identified at intragenic regions may coincide with regions
where menin could track the transcription process along the
gene as a component of protein complexes.
Therefore, the current analysis further highlights recent
evidence of the broad role of menin in transcriptional
regulation.
CpG Island Analysis of Menin-Occupied Loci
Menin-occupied loci were examined for the presence of
CpG islands within 2 kb of GSTs. Among the 1162 loci that
could be located near mRNA, CpG islands were found near
61% of menin-occupied loci that were near the 5V end of
genes, 5% of the 3V-end loci were near CpG islands, and 6%
of the loci inside genes were near CpG islands. For loci that
could not be located to mRNA, only 8% were near CpG
islands. Therefore, the possibility of a gene(s) being located
near these orphan loci could be very low. They might end up
being ‘‘inside’’ genes (intragenic) based on additional anno-
tations of the human genome.
When transcriptional regulatory proteins are shown to
occupy loci near the 3V end of genes or inside genes, bi-
directional or antisense transcription is generally suspected
to occur near such regions [18]. Based on the less abundant
occurrence of CpG islands near the menin-occupied loci that
were represented by GSTs mapping near the 3V end (5%
near CpG islands) or inside genes (6% near CpG islands)
compared to those near the 5V ends (61%), it is possible that
these loci may not occur near sites of bidirectional or anti-
sense transcription because such regulatory regions are
reported to be associated with CpG islands [32].
Functional Categories of Genes Occupied By Menin
To analyze the types of genes near menin-occupied loci,
Gene Ontology (GO) biological process categories were as-
signed to the 635 menin target genes by using GOstat [33].
Hypothetical genes (n = 157) were not considered for GO
assignment. Functional categories of 478 menin target genes
are summarized (Table 1). In comparison to the categories of
all genes, the most overrepresented categories are genes
important or predicted to be important in cellular metabolism
(51%),macromoleculemetabolism (33%), and cell cycle (7%).
In the GO function hierarchy, a few genes belong to multiple
categories and were thus scored more than once. The large
number of genes without annotations or functions did not
allow a thorough classification of the entire sample.
Correlation between Gene Occupancy and Expression
The occupancy of a locus by menin does not indicate
whether the gene is expressed, nor does it specify the
Table 1. Functional Categories of 478 Annotated Menin Target Genes Identified by SACO.
GO Term (Biological Process) Menin Targets*
[Gene Count (%)]
Human Genome*
[Gene Count (%)]
Py
Cellular metabolism 242 (51) 11,588 (41) 1.19E03
Macromolecule metabolism 156 (33) 7,104 (25) 5.13E03
Nucleobase, nucleotide, and nucleotide and nucleic
acid metabolism
115 (24) 4,916 (18) 4.19E03
Biopolymer metabolism 105 (22) 4,349 (16) 2.73E03
Regulation of cellular physiological process 104 (22) 4,207 (15) 1.31E03
Cell organization and biogenesis 58 (12) 1,985 (7) 1.07E03
Cell cycle 35 (7) 792 (3) 1.09E06
Transcription from RNA PolII promoter 26 (5) 500 (2) 1.50E03
Morphogenesis 24 (5) 615 (2) 1.19E03
Organismal physiological process 24 (5) 2,553 (9) 2.88E02
G-coupled protein receptor protein signaling pathway 10 (2) 1,491 (5) 2.73E02
Response to biotic stimulus 9 (2) 1,380 (5) 3.19E02
Functional categories are based on GO annotation (GOstat: http://gostat.wehi.edu.au).
Note that in GO function hierarchy, some genes belong to multiple categories.
GO terms 1 to 9 are overrepresented, and terms 10 to 12 are underrepresented in the list of menin target genes.
GO terms with similar representation in menin targets and in human genome are not shown.
*Percentage calculation: menin targets = 478; human genome = 28,042.
yCompared to human genome gene count for each category.
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direction of any regulation by menin. To find out the ex-
pression status of menin-occupied target genes, total RNA
preparations isolated from HeLa cells were analyzed for ex-
pression using oligonucleotide arrays. Among the 635 menin
target genes identified by SACO, a comparison of HeLa RNA
expression data and SACO data gave 614 genes for which
both menin occupancy and gene expression status were
available. Sixty-two percent of the menin-occupied genes
were expressed, compared to 40% of genes expressed for
the entire microarray, indicating that menin-occupied genes
are more likely to be transcribed (P < .003). When restricted
to expressed genes in HeLa cells, the representation of
genes where menin occupied the 5V end was similar to that
observed for the genomic occupancy of menin GSTs iden-
tified near the 5V end of genes (48% in genomic occupancy
vs 52% in expressed gene list). But the representation of
genes where menin occupied intragenic loci or 3V ends was
different from the genomic occupancy of menin at these
sites (intragenic loci: 31% in genomic occupancy vs 40% in
expressed gene list; 3V end loci: 21% in genomic occupancy
vs 9% in expressed gene list).
To further evaluate how the genes occupied by menin in
HeLa cells are modulated as a consequence of menin loss
in MEN1-associated human tumors or Men1-null MEFs,
a comparison with published gene expression array data
was made. The analysis showed that among the 15 genes
that were common between the menin targets identified by
SACO and the published gene expression data (Table W1),
eight genes were downregulated in islet tumors (that lack
menin). This correlation of menin-occupied genes and their
downregulation on menin loss in islet tumors is not sig-
nificant because the ‘‘islet tumor downregulated genes’’
category was overrepresented in the analysis compared to
other categories (143 of 319 genes that were considered
for comparison).
Menin shows a differential effect on transcription activated
by JunD versus c-Jun—two members of the AP1 family of
transcription factors [27,28]. To assess whether any of the
menin-occupied loci identified in this study correlates with
AP1-regulated genes, a list of 249 AP1-regulated genes
[34] was compared to menin-occupied target genes. The
analysis showed 10 genes that were common between the
menin targets identified by SACO and the published data
about AP1-regulated genes (Table W2). This correlation did
not yield any important data about menin interaction and
AP1-regulated genes except for Hoxa10, which has been
previously shown by ChIP–PCR as a menin target [10]
(Table W3), and DDR2, a gene involved in osteoarthritis
that is upregulated inmenin-complementedmenin-null MEFs
(Table W1). The 10 genes that were common targets were
identified as AP1-regulated genes using various methods
and various cells (as reported in Hayakawa et al. [34]). Infor-
mation about the directionality of their AP1-regulated tran-
scription is not known, and it is also not known if they are
JunD-regulated or c-Jun–regulated.
Future analysis of SACO-identified menin targets and
their transcriptional regulation under physiological and/or
pathological conditions should help extend our findings.
Modes of Menin Action
The many interactions of menin with proteins and with
‘‘genes’’ suggest two alternate models of menin action.
Protein interactions, mainly with JunD, indicate that menin
might initiate its action into only one pathway, for example,
by suppressing the activity of an oncogenic substrate JunD
[35]. In contrast, the current study, together with another
recent study [26], opens a new paradigm for the normal
and abnormal actions of menin. The genomic interactions
identified by SACO and ChIP chip point to the possibility of a
more complex nature of menin action. The new paradigm
involves action beginning at many genomic pathways.
Further work should explore whether these two models of
menin action are complementary.
Conclusions
A substantial sampling of themenin–SACO library for menin-
occupied loci in genomic chromatin showed that menin was
not confined, in part, to a large number of promoter regions
but that menin could also occupy many other regions inside
genes and at the 3V ends of genes. These data suggest
that new as yet unidentified regulatory sequences could be
present at those intragenic loci occupied by menin, or they
could be regions where menin tracks with transcriptional
progression. Menin’s functions at the 1162 genomic loci
and the nature of the DNA sequence at these loci remain to
be established.
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